402 related articles for article (PubMed ID: 8320741)
1. Mortality from second tumors among long-term survivors of retinoblastoma.
Eng C; Li FP; Abramson DH; Ellsworth RM; Wong FL; Goldman MB; Seddon J; Tarbell N; Boice JD
J Natl Cancer Inst; 1993 Jul; 85(14):1121-8. PubMed ID: 8320741
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP
JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268
[TBL] [Abstract][Full Text] [Related]
3. Cause-specific mortality in long-term survivors of retinoblastoma.
Yu CL; Tucker MA; Abramson DH; Furukawa K; Seddon JM; Stovall M; Fraumeni JF; Kleinerman RA
J Natl Cancer Inst; 2009 Apr; 101(8):581-91. PubMed ID: 19351917
[TBL] [Abstract][Full Text] [Related]
4. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
5. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
6. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
7. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
8. Cancer mortality in long-term survivors of retinoblastoma.
Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
[TBL] [Abstract][Full Text] [Related]
9. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis.
Jiménez I; Laé M; Tanguy ML; Savignoni A; Gauthier-Villars M; Desjardins L; Cassoux N; Dendale R; Rodriguez J; Doz F; Brisse HJ; Aerts I
Pediatr Blood Cancer; 2020 Apr; 67(4):e28158. PubMed ID: 31904159
[TBL] [Abstract][Full Text] [Related]
10. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
11. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
12. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
13. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994.
Moll AC; Imhof SM; Bouter LM; Kuik DJ; Den Otter W; Bezemer PD; Koten JW; Tan KE
Int J Cancer; 1996 Aug; 67(4):515-9. PubMed ID: 8759610
[TBL] [Abstract][Full Text] [Related]
14. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma.
Abramson DH; Melson MR; Dunkel IJ; Frank CM
Ophthalmology; 2001 Oct; 108(10):1868-76. PubMed ID: 11581064
[TBL] [Abstract][Full Text] [Related]
15. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.
Little MP; Schaeffer ML; Reulen RC; Abramson DH; Stovall M; Weathers R; de Vathaire F; Diallo I; Seddon JM; Hawkins MM; Tucker MA; Kleinerman RA
Br J Cancer; 2014 May; 110(10):2623-32. PubMed ID: 24755883
[TBL] [Abstract][Full Text] [Related]
17. RB1 mutations and second primary malignancies after hereditary retinoblastoma.
Dommering CJ; Marees T; van der Hout AH; Imhof SM; Meijers-Heijboer H; Ringens PJ; van Leeuwen FE; Moll AC
Fam Cancer; 2012 Jun; 11(2):225-33. PubMed ID: 22205104
[TBL] [Abstract][Full Text] [Related]
18. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma.
Smith LM; Donaldson SS; Egbert PR; Link MP; Bagshaw MA
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):499-505. PubMed ID: 2777644
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
20. Cancer mortality in relatives of retinoblastoma patients.
Strong LC; Herson J; Haas C; Elder K; Chakraborty R; Weiss KM; Majumder P
J Natl Cancer Inst; 1984 Aug; 73(2):303-11. PubMed ID: 6589425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
